Caribou Biosciences (CRBU) Other Operating Expenses (2025)

Caribou Biosciences (CRBU) posted quarterly Other Operating Expenses of $12.1 million for Q2 2025.

Caribou Biosciences (CRBU) Other Operating Expenses (2025) Analysis & Trends

Caribou Biosciences (CRBU) has reported Other Operating Expenses for 1 consecutive years, with $12.1 million the latest figure, recorded in Q2 2025.

In Q2 2025, Other Operating Expenses changed N/A year-over-year to $12.1 million; the TTM figure through Mar 2026 stood at $12.1 million (changed N/A YoY), while the FY2025 annual figure was $12.1 million, changed N/A from the prior year.
Other Operating Expenses held at $12.1 million in Q2 2025 per CRBU's latest filing.
Across five years, Other Operating Expenses topped out at $12.1 million in Q2 2025 and bottomed at $12.1 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Caribou Biosciences	166.63 Mn	54.31 Mn	-

Download Data

Date	Value
Jun 30, 2025	12.15 Mn